PARTNER
About us
WNS, an NYSE-listed leading Business Process Management (BPM) company, has a global presence spanning 16 countries with 46,000+ employees and 57 delivery centers. WNS co-creates innovative, digitally led transformational solutions with over 375 clients across various industries including healthcare and life sciences. WNS delivers an entire spectrum of BPM solutions, including industry-specific offerings, finance and accounting (F&A), customer experience services, human resources, procurement, and research and analytics (R&A), to help clients re-imagine their business digitally.
WNS partners with 35+ global healthcare organizations and 12 of the world’s top 20 life sciences brands to co-create industry-leading care management and telehealth solutions, and transform their F&A, procurement and commercial processes leveraging domain expertise, analytics and digital.
WNS offers an entire gamut of F&A solutions, including the industry-first Quote-to-Sustain (QtS) offering that re-invents traditional and siloed Order-to-Cash, Record-to-Report (R2R), Procure-to-Pay (P2P) and more. WNS’ strong penchant for unlocking next-generation and transformative value for CFOs through innovative solutions and frameworks has been well-recognized by the industry.
WNS has been helping healthcare payer and provider communities adapt to a landscape altered by COVID-19 while prioritizing patient-centered outcomes and growth. For providers, WNS drives end-to-end Revenue Cycle Management (RCM) and clinical operations management, and offers collaborative care management solutions to improve patient well-being while reducing cost-to-serve. WNS’ depth of clinical expertise translates into robust outcomes across utilization management, medical and case management, provider management, claims intake, and adjudication and medical bill review for payers. WNS’ ever-expanding capabilities have earned it industry-wide recognition, including being recognized as an overall ‘Leader’ in NelsonHall’s 2021 NEAT evaluation for Healthcare Payer business process services.
WNS enables life sciences companies to find sustainable value in a landscape marked by diminishing R&D returns, increasing costs, rising pricing pressures, growing regulatory demands, and accelerated influence of the non-medical ecosystem. WNS helps them drive faster commercial success with comprehensive portfolio of R&A solutions, including cloud, and artificial intelligence and machine learning-led products and platforms such as PRECIZON and SocioSeerTM.
Learn More
A Leading Regenerative Medical Devices Company Forays into North America
A Top Speciality Home Medical Equipment Supplier Transforms Revenue Cycle Operations
Revenue Cycle Management Transformation
Learn More
CFOs & the Key Focus Areas to Build a Future-ready Organization
An Industry-first Offering Creates a Game-changing Shift to Digital Finance
Driving Finance Optimization with Smart Processes, Analytics & Digital Automation
Learn more about how WNS is helping global CFOs re-imagine finance, and achieve the next frontier in efficiency and effectiveness.
Contact us about Partnership Opportunities

For more information on partnership opportunities at other FT Live events, get in touch today to see how you can get involved.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice